Abbott Laboratories (NYSE:ABT) discovers, develops, manufactures and sells healthcare products worldwide. It is set to report ...

Abbott Laboratories (NYSE:ABT – Get Free Report) was downgraded by equities researchers at StockNews.com from a “strong-buy” ...

Abbott Laboratories ABT faced industry-wide challenges that exerted pressure on its profit margins. Factors such as rising ...

We recently published a list of the 10 Best Medical Device Stocks To Buy According to Hedge Funds. In this article, we are ...

This month, we explore the 125-year-old history of Abbott Laboratories and its most significant milestone to date – the creation of its own independent company, AbbVie. In 1888, a 30-year-old ...

Abbott Laboratories is being sued over how it pitches such products. Abbott, a health care products conglomerate based in Illinois, is misleading parents and other caregivers about the nutritional ...

Senator Markwayne Mullin (R-Oklahoma) recently sold shares of Abbott Laboratories (NYSE:ABT). In a filing disclosed on January 31st, the Senator disclosed that they had sold between $1,001 and $15,000 ...

A U.K. court has ruled against Abbott in a trademark infringement case the company had brought over the design of a rival ...

Sinocare announced recently that it successfully defended itself in court against trademark infringement claims brought by ...

Shares of Abbott India surged 5.60% higher at ₹27,605.45 on the BSE on Tuesday. The pharma stock reacted positively to the ...